Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Suppressor of Cytokine Signaling 7 (SOCS7) (N-Term) Peptide

SOCS7 Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN5513469

Aperçu rapide pour Suppressor of Cytokine Signaling 7 (SOCS7) (N-Term) Peptide (ABIN5513469)

Antigène

SOCS7 (Suppressor of Cytokine Signaling 7 (SOCS7))

Origine

Humain

Source

  • 4
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Séquence

    GSAGRELDAG RKPKLTRTQS AFSPVSFSPL FTGETVSLVD VDISQRGLTS

    Attributs du produit

    This is a synthetic peptide designed for use in combination with anti-SOCS7 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    SOCS7 (Suppressor of Cytokine Signaling 7 (SOCS7))

    Sujet

    SOCS7 regulates signaling cascades probably through protein ubiquitination and/or sequestration. It functions in insulin signaling and glucose homeostasis through IRS1 ubiquitination and subsequent proteasomal degradation. It inhibits also prolactin, growth hormone and leptin signaling by preventing STAT3 and STAT5 activation, sequestering them in the cytoplasm and reducing their binding to DNA. SOCS7 may be a substrate recognition component of a SCF-like E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.

    Protein Size: 331

    ID gène

    30837
Vous êtes ici:
Chat with us!